4 research outputs found
Palladium-Catalyzed C–H Arylation of Indoles at the C7 Position
In the past decade, direct C–H
arylation of indoles has
been developed with high selectivity at the C2 and C3 positions via
transition-metal-catalyzed cross-coupling reactions. Here we show
that C–H activation can be directed to the C7 position with
high selectivity in Pd-catalyzed coupling of indoles with arylboronic
acids. The key to this high regioÂselectivity is the appropriate
choice of a phosphinoyl directing group and a pyridine-type ligand
in the presence of PdÂ(OAc)<sub>2</sub> catalyst. This previously elusive
transformation should provide insight for the design of other cross-couplings
as well
Copper-Catalyzed <i>N</i>‑Benzoylation of Amines via Aerobic C–C Bond Cleavage
A general
copper/air catalytic system for selectively oxidative
C–C bond cleavage of 1,2-diarylethan-1-one has been developed,
giving aromatic aldehydes and <i>N</i>-benzoylation products
of various amines in moderate to excellent yields. This research provides
an alternative approach for the <i>N</i>-benzoylation of
amine in mild and neutral conditions
Cu-Catalyzed Direct C6-Arylation of Indoles
The
first example of direct and site-selective arylation of indoles
at the C6 position has been reported. The key to this high regioselectivity
is the appropriate choice of the N–PÂ(O)<sup><i>t</i></sup>Bu<sub>2</sub> directing group and the use of diaryliodonium
triflate salts as the coupling partners in the presence of catalytic
CuO. The protocol is distinguished by mild reaction system that avoids
ligand and additives, exhibiting wide scope of indole and arene coupling
components without compromising its efficiency and scalability, thus
representing a significant advancement in the implementation of regioselective
direct arylation of indoles
Mononostril versus Binostril Endoscopic Transsphenoidal Approach for Pituitary Adenomas: A Systematic Review and Meta-Analysis
<div><p>Background</p><p>Over the past several decades, the endoscopic endonasal transsphenoidal approach (EETA) has gradually become a preferred option of pituitary adenomas surgery because of its minimal invasiveness and high efficiency. However, some EETA operations were performed through one nostril (mononostril), while other EETA operations were performed through both nostrils (binostril). Therefore, we conducted this study to compare the pros and cons of these two methods in an attempted to confirm which method is more effective.</p><p>Methods</p><p>We executed a systematic literature search of PubMed, the Cochrane Library, and the Web of Science and Medline (1992–2015). The language is limited to English and all studies should meet the inclusion criteria. Comparisons were made for postoperative outcomes, complications, and other relevant parameters between the mononostril and the binostril group. Statistical analyses of categorical variables were undertaken by the use of Stata 12.0 and SPASS 19.0.</p><p>Results</p><p>Thirty studies, involving 4805 patients, were included. The two groups had similar results in GTR rate (included GTR rate of macroadenomas), hormonal remission rate, improvement in visual function, postoperative CSF leak, permanent diabetes insipidus, meningitis, and sinusitis. The binostril group had less temporary diabetes insipidus (2.9% vs. 5.3%, p = 0.022), less anterior pituitary insufficiency (2.3% vs. 6.4%, p = 0.000) and few hospitalization days (3.2 days vs. 4.4 days, p<0.05) than the mononostril group. However, the mononostril group had less rate of epistaxis (0.4% vs. 1.5%, p = 0.008) than the binostril group. For invasive macroadenomas, the binostril group seem to demonstrate a tendency towards better outcomes though there was no subgroup analysis between the two groups.</p><p>Conclusion</p><p>The binostril approach had less temporary diabetes insipidus, anterior pituitary insufficiency, and a shorter length of hospital stay, although they demonstrated a higher rate of epistaxis than the mononstril group. Additionally, the binostril group seemed to suggest a tendency towards better outcomes for invasive macroadenomas.</p></div